MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples